RxDoctor Payments Data

Brooke Walterscheid

Lubbock, TXNPI 1750969960

Payments from drug & device makers

$6,117in general payments, 2019–2025

Across 137 payments — averaging $44.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$740
  • Novartis$685
  • Regeneron Healthcare Solutions, Inc.$595
  • AbbVie$571
  • Galderma Laboratories, L.p.$554
  • Boehringer Ingelheim$524
  • plus $2K from 13 others

What the payments were for

  • Food & beverage$6,117100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate61$2,526
Fluorouracil26$1,480
Metronidazole16$1,037
Doxycycline Monohydrate15$871
Ketoconazole69$694
Triamcinolone Acetonide38$418
Doxycycline Hyclate11$274
Hydrocortisone17$169
Nystatin16$143
Minoxidil18$122
Finasteride15$87
Mupirocin11$64

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →